Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complexed prostate-specific antigen improvement in detecting prostate cancer.

K Okihara1, R J Babaian

  • 1Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4095, USA. okiharaji@hotmail.com

Current Urology Reports
|June 27, 2002
PubMed
Summary

Complexed prostate-specific antigen (PSA) assays show promise for improving prostate cancer detection. Further research is needed to confirm the variability and clinical utility of these complexed PSA markers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of PSF1 as a prognostic biomarker for prostate cancer.

Prostate cancer and prostatic diseases·2014
Same author

The beneficial effect of propolis on fat accumulation and lipid metabolism in rats fed a high-fat diet.

Journal of food science·2009
Same author

Topical application of royal jelly has a healing effect for 5-fluorouracil-induced experimental oral mucositis in hamsters.

Methods and findings in experimental and clinical pharmacology·2008
Same author

Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance.

The Journal of urology·2007
Same author

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

International journal of radiation oncology, biology, physics·2003
Same author

Sural nerve graft during non-nerve-sparing radical retropubic prostatectomy restores erectile function in patients with locally advanced prostate cancer.

Prostate cancer and prostatic diseases·2002

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Prostate-specific antigen (PSA) is a key biomarker for prostate cancer.
  • Current limitations exist in differentiating benign conditions from prostate cancer using total PSA alone.
  • Complexed forms of PSA are being investigated to improve diagnostic accuracy.

Purpose of the Study:

  • To review current reports on complexed prostate-specific antigen (PSA) assays.
  • To evaluate the potential of complexed PSA for enhancing prostate cancer detection.
  • To assess the diagnostic value of different complexed PSA forms.

Main Methods:

  • Review of existing literature on complexed PSA assays.
  • Analysis of comparative studies involving various PSA markers.
  • Evaluation of preliminary data for novel complexed PSA assays.

Related Experiment Videos

Main Results:

  • Volume-referenced complexed PSA (PSA-ACT and cPSA) may improve prostate cancer detection.
  • The additive value of PSA-ACT and cPSA in men with intermediate PSA levels remains debated.
  • Emerging assays like PSA-alpha(2)-macrobloblin (PSA-a(2)M) and PSA-alpha(1)-protease inhibitor (PSA-API) show potential.

Conclusions:

  • Complexed PSA assays offer a promising avenue for enhanced prostate cancer detection.
  • Further studies are required to clarify the variability and clinical application of complexed PSA.
  • Novel complexed PSA markers warrant continued investigation for improved diagnostics.